Quanterix Corp (QTRX): Revenue
$138.90M
Year ended 2025-12-31
$153.41M
Trailing 12 months to 2026-06-30
+9.6%
3-year compound annual growth
+10.0%
5-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $138.90M | +1.1% | 2026-03-02, From 2025-01-01 |
| 2024-12-31 | $137.42M | +12.3% | 2026-03-02, From 2024-01-01 |
| 2023-12-31 | $122.37M | +16.0% | 2026-03-02, From 2023-01-01 |
| 2022-12-31 | $105.52M | -4.6% | 2025-03-17, From 2022-01-01 |
| 2021-12-31 | $110.56M | +28.0% | 2024-12-26, From 2021-01-01 |
| 2020-12-31 | $86.38M | +52.2% | 2023-03-06, From 2020-01-01 |
| 2019-12-31 | $56.73M | +50.8% | 2022-03-01, From 2019-01-01 |
| 2018-12-31 | $37.63M | +64.5% | 2021-03-05, From 2018-01-01 |
| 2017-12-31 | $22.87M | +30.1% | 2020-03-13, From 2017-01-01 |
| 2016-12-31 | $17.59M | n/a | 2019-03-18, From 2016-01-01 |
Revenue at similar companies
| Company | Year ended | Revenue | Change YoY |
|---|---|---|---|
| Quanterix Corp (QTRX) | 2025-12-31 | $138.90M | +1.1% |
| Pacific Biosciences of California, Inc. (PACB) | 2025-12-31 | $160.00M | +3.9% |
| Cytek Biosciences, Inc. (CTKB) | 2025-12-31 | $201.49M | +0.5% |
| Harvard Bioscience Inc (HBIO) | 2025-12-31 | $86.55M | -8.1% |
| 908 Devices Inc. (MASS) | 2025-12-31 | $56.20M | +17.7% |
| Rapid Micro Biosystems, Inc. (RPID) | 2025-12-31 | $33.59M | +19.7% |
| EyePoint, Inc. (EYPT) | 2025-12-31 | $31.37M | -27.5% |
| 10x Genomics, Inc. (TXG) | 2025-12-31 | $642.82M | +5.2% |
| Bionano Genomics, Inc. (BNGO) | 2025-12-31 | $28.51M | -7.4% |
Compare QTRX, PACB, CTKB, HBIO side by side · Screen every company in Laboratory Analytical Instruments ↗